“A homeopathically prepared remedy, HIV nosode 30c was tested for its possible anticancer potential and therapeutic use against cancer as revealed from a recent study on A-549 lung cancer cells conducted in our lab…”
The evidence shows that patients, not physicians, are the primary impetus for the increasing call for homeopathic cancer treatment worldwide. In the countries where homeopathic treatment is available, treatment is often provided in the absence of good professional references on homeopathic cancer drugs.
Migraines; DNA Affects & Homeopathy; Homeopathy 4 Cancer
Hering’s Law of Cure; Testimonial “Maturity through Homeopathic treatment”; Homeopathy has anti-cancer effect on liver cancer; Homeopathic drugs modify gene expression in cervical cancer cells; Article on Cancer Predisposition (diathesis)
Thus, the highly-diluted, dynamized homeopathic remedies LC-5C and LC-15C demonstrated their capabilities to induce apoptosis in cancer cells, signifying their possible use as supportive medicines in cancer therapy.
Psorinum 6× triggered apoptosis in A549 cells via both up- and down-regulations of relevant signal proteins, including p53, caspase-3, Bax and Bcl-2.
I was diagnosed with a carcinoma of the parotid gland in December, 2013.
I submitted myself to surgery for removal of the gland and 37 radiation treatments in early 2014.
When I was diagnosed with breast cancer five and a half years ago, my life changed almost overnight. I was not “supposed” to get cancer because I did not do any of those things that they say cause cancer. I did not drink, smoke or do drugs. I did not have any family history of…
Complement Ther Med. 2014 Apr;22(2):320-32. doi: 10.1016/j.ctim.2013.12.014. Epub 2014 Jan 8.
Additive homeopathy in cancer patients: Retrospective survival data from a homeopathic outpatient unit at the Medical University of Vienna.
Gaertner K1, Müllner M2, Friehs H2, Schuster E3, Marosi C2, Muchitsch I4, Frass M5, Kaye AD6.
Author information
Abstract
BACKGROUND:
Current literature suggests a positive influence of additive classical homeopathy on global health and well-being in cancer patients. Besides encouraging case reports, there is little if any research on long-term survival of patients who obtain homeopathic care during cancer treatment.
DESIGN:
Data from cancer patients who had undergone homeopathic treatment complementary to conventional anti-cancer treatment at the Outpatient Unit for Homeopathy in Malignant Diseases, Medical University Vienna, Department of Medicine I, Vienna, Austria, were collected, described and a retrospective subgroup-analysis with regard to survival time was performed. Patient inclusion criteria were at least three homeopathic consultations, fatal prognosis of disease, quantitative and qualitative description of patient characteristics, and survival time.
RESULTS:
In four years, a total of 538 patients were recorded to have visited the Outpatient Unit Homeopathy in Malignant Diseases, Medical University Vienna, Department of Medicine I, Vienna, Austria. 62.8% of them were women, and nearly 20% had breast cancer. From the 53.7% (n=287) who had undergone at least three homeopathic consultations within four years, 18.7% (n=54) fulfilled inclusion criteria for survival analysis. The surveyed neoplasms were glioblastoma, lung, cholangiocellular and pancreatic carcinomas, metastasized sarcoma, and renal cell carcinoma. Median overall survival was compared to expert expectations of survival outcomes by specific cancer type and was prolonged across observed cancer entities (p<0.001).
CONCLUSION:
Extended survival time in this sample of cancer patients with fatal prognosis but additive homeopathic treatment is interesting. However, findings are based on a small sample, and with only limited data available about patient and treatment characteristics. The relationship between homeopathic treatment and survival time requires prospective investigation in larger samples possibly using matched-pair control analysis or randomized trials.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Manfred continues the work of Samuel Hahnemann by applying the concepts from the Organon to today’s homeopathic practice. Diseases of today are more complex than in Samuel Hahnemann’s time [more than 200 years ago]. Our chronic disorders are mostly iatrogenic (drug/poison induced). Learn how to use new tools to accomplish more with your patients – faster and gentler.